Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer

Fei Xing1, Hongli Gao1, Guanglei Chen1

  • 1Department of Oncology, Innovative Cancer Drug Research and Engineering Center of Liaoning Province, Cancer Stem Cell and Translation Medicine Lab, Shengjing Hospital of China Medical University, Shenyang, 110022, China.

Molecular Cancer
|April 14, 2025
PubMed
Abstract

No abstract available in PubMed .